Prostatis Group LLC Abb Vie Inc. Transaction History

Prostatis Group LLC

$215 Billion
Q2 2023

A detailed history of Prostatis Group LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Prostatis Group LLC holds 63,516 shares of ABBV stock, worth $11.5 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

63,516

Previous 1,431 4338.57%

Holding current value

$11.5 Million

Previous $215 Million 8.24%

% of portfolio

0.09%

Previous 0.11%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $8.23 Million - $10.2 Million	62,085 Added 4338.57%	63,516 $197 Million
Q1 2023 May 22, 2023	SELL	$144.61 - $166.54 $1,446 - $1,665	-10 Reduced 0.69%	1,431 $215 Million
Q4 2022 Mar 28, 2023	SELL	$138.31 - $165.87 $9.55 Million - $11.5 Million	-69,063 Reduced 97.96%	1,441 $233 Million
Q4 2022 Mar 23, 2023	BUY	$138.31 - $165.87 $5.9 Million - $7.08 Million	42,661 Added 153.22%	70,504 $233 Million
Q3 2022 Mar 23, 2023	SELL	$134.21 - $153.93 $509,729 - $584,626	-3,798 Reduced 12.0%	27,843 $161 Million
Q2 2022 Mar 23, 2023	SELL	$137.62 - $174.96 $246,339 - $313,178	-1,790 Reduced 5.35%	31,641 $185 Million
Q1 2022 Mar 23, 2023	BUY	$131.98 - $163.75 $705,037 - $874,752	5,342 Added 19.02%	33,431 $196 Million
Q4 2021 Mar 23, 2023	BUY	$107.43 - $135.93 $591,509 - $748,430	5,506 Added 24.38%	28,089 $164 Million
Q3 2021 Mar 23, 2023	SELL	$106.4 - $120.78 $341,224 - $387,341	-3,207 Reduced 12.44%	22,583 $130 Million
Q2 2021 Mar 23, 2023	BUY	$105.21 - $117.21 $330,675 - $368,391	3,143 Added 13.88%	25,790 $138 Million
Q1 2021 Mar 23, 2023	BUY	$102.3 - $112.62 $22,506 - $24,776	220 Added 0.98%	22,647 $130 Million
Q4 2020 Mar 23, 2023	BUY	$80.49 - $108.67 $315,520 - $425,986	3,920 Added 21.18%	22,427 $128 Million
Q3 2020 Mar 23, 2023	SELL	$85.91 - $100.83 $181,356 - $212,852	-2,111 Reduced 10.24%	18,507 $104 Million
Q2 2020 Mar 23, 2023	BUY	$73.37 - $98.18 $330,605 - $442,399	4,506 Added 27.97%	20,618 $116 Million
Q1 2020 Mar 23, 2023	SELL	$64.5 - $97.79 $161,572 - $244,963	-2,505 Reduced 13.46%	16,112 $81.8 Million
Q4 2019 Mar 23, 2023	BUY	$72.13 - $90.25 $1.34 Million - $1.68 Million	18,617 New	18,617 $98.2 Million

Others Institutions Holding ABBV

# of Institutions

3,849

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $320B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prostatis Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prostatis Group LLC with notifications on news.

Account

Prostatis Group LLC Abb Vie Inc. Transaction History